Glytec And Nebraska Medicine Establish Strategic Partnership to Advance Patient Safety and Innovation Around Insulin Management
Retrieved on:
Tuesday, January 25, 2022
Software, Pharmaceutical, Nursing, Health, Diabetes, Data Management, Hospitals, Technology, University, Infection, Hypoglycemia, Lists of diseases, Death, Patient, Nursing, Bellevue Medical Center, EHR, Technology, Medicine, IV, Hospital, Insulin, Population, E-GMS, FDA, CMS, Information technology, Metabolism, FACP, Information Communications Technology education in the Philippines, Research, Organization, Patient safety, Fuel injection, Diagnosis, Nebraska Medicine, Bed, LinkedIn, Environment, Hyperglycemia, Safety, Health, Caregiver, Leadership, Partnership, University of Nebraska Medical Center, Medical device, Management, Pharmaceutical industry, Endocrinology, Diabetes, MD, Nebraska Medicine, Glytec, NEBRASKA MEDICINE, GLYTEC
Glytec , the only provider of cloud-based insulin management software across the continuum of care, today announced a new strategic partnership with Nebraska Medicine to advance patient safety and innovation around insulin management.
Key Points:
- Glytec , the only provider of cloud-based insulin management software across the continuum of care, today announced a new strategic partnership with Nebraska Medicine to advance patient safety and innovation around insulin management.
- Nebraska Medicine will implement Glytecs eGlycemic Management System (eGMS) across all 800 beds at its two hospitals Nebraska Medical Center and Bellevue Medical Center.
- In addition, Nebraska Medicine and Glytec will join forces on research and development initiatives to improve the safety and efficacy of insulin management across all hospital departments.
- Through this partnership, Glytec and Nebraska Medicine will collaborate closely on research and pilot programs for improving inpatient insulin management using Glytecs computer-guided dosing software.